Clinical Trials Logo

Pregnancy clinical trials

View clinical trials related to Pregnancy.

Filter by:

NCT ID: NCT00654771 Completed - Hypertension Clinical Trials

Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation

UPREE
Start date: July 2005
Phase: N/A
Study type: Observational

The purpose of this prospective study was to examine whether protein/creatinine ratios in catheterized urine specimens correlate to clean catch specimens in pregnant patients being evaluated for preeclampsia.

NCT ID: NCT00647595 Completed - Obesity Clinical Trials

Effect of Physical Activity on Metabolic Syndrome in Pregnancy & Fetal Outcome

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the effect of exercise during pregnancy upon maternal metabolism, including weight gain, fat distribution, and levels of glucose and cholesterol. We will also conduct a pilot study to examine the feasibility of studying the health of infants born to women in this study.

NCT ID: NCT00646360 Completed - Pregnancy Clinical Trials

Effects of Prenatal DHA Supplements on Infant Development

Start date: February 2005
Phase: N/A
Study type: Interventional

This research study research is about the significance of polyunsaturated fatty acids (PUFAs) for human development. Specifically, the study team will assess the effect of docosahexanoic acid (DHA) supplementation during pregnancy on infant growth and development through a randomized controlled intervention trial in Cuernavaca, Mexico. This is a collaborative effort between the Rollins School of Public Health, Emory University, the Instituto Nacional de Salud Publica (INSP) and the Instituto Mexicano del Seguro Social (IMSS), Cuernavaca, Mexico. Pregnant women attending the IMSS General Hospital I are recruited between 18-22 weeks gestation and assigned randomly to receive either DHA (400 mg) or a placebo daily until delivery. The main study outcomes include a) birth outcomes: birth size, gestational age, cord blood levels of DHA and neurodevelopment b) maternal blood and breast milk DHA levels at 1 and 3 months post-partum, c) postnatal growth and development during the first 5 years of age and d) infant DHA status at 3, 12 and 18 months.

NCT ID: NCT00642980 Completed - Pregnancy Clinical Trials

Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis

PREMEVA
Start date: April 2006
Phase: Phase 4
Study type: Interventional

Background. Anomalies of the vaginal flora (bacterial vaginosis, BV) are associated with an increased risk of late abortions and preterm birth. Studies of antibiotic treatment of BV to reduce the risk of prematurity have not found a statistically significant diminution of risk (<= 32 wks: OR=0.49 [0.05-5.1], < 37 wks: OR=0.83 [0.59-1.17]).A partial explanation of these findings is that some of these treatment were administered vaginally, most often during the second or third trimester Aim: To reduce the frequency of late abortions and very preterm birth by prescribing clindamycin vs placebo to patients diagnosed with BV before 13 weeks.

NCT ID: NCT00641862 Completed - Pregnancy Clinical Trials

Randomized Trial of Vitamin B12 in Pregnant Indian Women

B12
Start date: December 2008
Phase: N/A
Study type: Interventional

This study is a randomized, double-blind trial among 300 pregnant Indian women in order to determine the effectiveness of vitamin B12 supplementation in improving maternal B12 status. Secondary aims for this trial include maternal hemoglobin, maternal weight gain during pregnancy and infant birthweight. All women will receive standard of prenatal obstetric care, including routine supplementation with iron and folate.

NCT ID: NCT00639964 Completed - Clinical trials for Type 2 Diabetes Mellitus

Exploration of the Lipid Metabolism During the Diabetic Pregnancies

DIAMANT
Start date: January 2008
Phase: N/A
Study type: Interventional

Justification: Intrauterine exposure to type 1 or type 2 diabetes increase the risk of macrosomia (35 % to 50 % versus 10 % in general population) despite a good glycemic control. The consequences are : shoulder's dystocia, lung immaturity, caesarean section, neonatal hypoglycaemia and a high frequency of obesity and metabolic disorders in adults. The mechanisms of macrosomia are unclear; chronic hyperglycemia and subsequent hyperinsulinaemia observed during the diabetic pregnancy might explain only partially the fetal weight. Considerable interest has been generated over the last decade on the lipids and fatty acids alterations in diabetes pregnancies. Change in lipoproteins metabolism have been described associated with macrosomia. Maternal nutrition before and during pregnancy plays an important role in fetal growth and subsequent development of an increased susceptibility to obesity and diabetes in later life. Main objective: Looking for an association between maternal and fetal blood lipid parameters and birth weight and body fat in a context of type 1 or type 2 diabetes. Secondary objectives: - Identify lipid markers associated with fetal macrosomia. - Analyze the placenta by measuring the expression of genes implicated in the storage and the transfer of fatty acids. - Analyze and compare the expression level of placental genes subjected to parental imprinting and validated in animal models.

NCT ID: NCT00635947 Completed - Pregnancy Clinical Trials

Study of Maternal Hydration on the Increase of Amniotic Fluid Index

Start date: July 1998
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of maternal hydration with oral isotonic solution and water on amniotic fluid (AF) index in women with normohydramnios.

NCT ID: NCT00635258 Completed - Pregnancy Clinical Trials

Administration of GnRH Antagonist to Oocyte Donation Recipients

GnRH-Ovodon
Start date: January 2004
Phase: N/A
Study type: Observational

This prospective and randomized study was performed to evaluate whether the replacement of GnRH agonist by a GnRH antagonist in oocyte donation recipients during endometrial preparation has any impact on pregnancy and implantation rates.

NCT ID: NCT00632476 Completed - Pregnancy Clinical Trials

Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women

Start date: March 2007
Phase: N/A
Study type: Interventional

Women who smoke during their pregnancy place their unborn child at an increased risk of health problems, including decreased lung function and possible lung diseases later in life. Preliminary animal research suggests that if vitamin C is taken during pregnancy, nicotine's harmful effects on the unborn baby's developing lungs may be blocked. This study will determine the effect that vitamin C has on the lung development and function of babies born to women who smoke during pregnancy.

NCT ID: NCT00629369 Completed - Pregnancy Clinical Trials

Duration of Second Stage of Labor Wearing a Dental Occlusion Device

Start date: October 2007
Phase: N/A
Study type: Interventional

Developing a method to maximize maternal expulsive effort should be of great value in reducing the number of cesarean section or instrumental deliveries. Various investigations have shown that use of an occlusal support device (OSD) increases the isometric strength of different muscle groups. The aim of our study was to investigate the role of an OSD in second stage pushing.